» Articles » PMID: 23508043

Gliotoxicity of the Cyanotoxin, β-methyl-amino-L-alanine (BMAA)

Overview
Journal Sci Rep
Specialty Science
Date 2013 Mar 20
PMID 23508043
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

The amino acid variant β-methyl-amino-L-alanine (BMAA) has long been associated with the increased incidence and progression of the amyotrophic lateral sclerosis/Parkinsonism dementia complex (ALS/PDC). Previous studies have indicated that BMAA damages neurons via excitotoxic mechanisms. We have challenged rat olfactory ensheathing cells (OECs) with exogenous BMAA and found it to be cytotoxic. BMAA also induces a significant increase in Ca2+ influx, enhanced production of reactive oxygen species (ROS), and disrupts mitochondrial activity in OECs. This is the first study investigating BMAA toxicity using pure glial cells. These findings align BMAA with the three proposed mechanisms of degeneration in ALS, those being non-cell autonomous death, excitotoxicity and mitochondrial dysfunction.

Citing Articles

A neuron-immune circuit regulates neurodegeneration in the hindbrain and spinal cord of Arf1-ablated mice.

Wang G, Jin S, Liu J, Li X, Dai P, Wang Y Natl Sci Rev. 2024; 10(12):nwad222.

PMID: 38239560 PMC: 10794899. DOI: 10.1093/nsr/nwad222.


Freshwater Cyanobacterial Toxins, Cyanopeptides and Neurodegenerative Diseases.

Nugumanova G, Ponomarev E, Askarova S, Fasler-Kan E, Barteneva N Toxins (Basel). 2023; 15(3).

PMID: 36977124 PMC: 10057253. DOI: 10.3390/toxins15030233.


β-N-Methylamino-L-Alanine (BMAA) Modulates the Sympathetic Regulation and Homeostasis of Polyamines.

Shkodrova M, Mishonova M, Chichova M, Sazdova I, Ilieva B, Doncheva-Stoimenova D Toxins (Basel). 2023; 15(2).

PMID: 36828455 PMC: 9960692. DOI: 10.3390/toxins15020141.


Detection of β-N-methylamino-l-alanine in postmortem olfactory bulbs of Alzheimer's disease patients using UHPLC-MS/MS: An autopsy case-series study.

Garamszegi S, Banack S, Duque L, Metcalf J, Stommel E, Cox P Toxicol Rep. 2023; 10:87-96.

PMID: 36691605 PMC: 9860447. DOI: 10.1016/j.toxrep.2023.01.002.


Environmental Neurotoxin β--Methylamino-L-alanine (BMAA) as a Widely Occurring Putative Pathogenic Factor in Neurodegenerative Diseases.

Lopicic S, Svircev Z, Palanacki Malesevic T, Kopitovic A, Ivanovska A, Meriluoto J Microorganisms. 2022; 10(12).

PMID: 36557671 PMC: 9781992. DOI: 10.3390/microorganisms10122418.


References
1.
Chiu A, Gehringer M, Braidy N, Guillemin G, Welch J, Neilan B . Excitotoxic potential of the cyanotoxin β-methyl-amino-L-alanine (BMAA) in primary human neurons. Toxicon. 2012; 60(6):1159-65. DOI: 10.1016/j.toxicon.2012.07.169. View

2.
Mazzarello P, Poloni M, Spadari S, Focher F . DNA repair mechanisms in neurological diseases: facts and hypotheses. J Neurol Sci. 1992; 112(1-2):4-14. DOI: 10.1016/0022-510x(92)90125-5. View

3.
Corti S, Locatelli F, Papadimitriou D, Del Bo R, Nizzardo M, Nardini M . Neural stem cells LewisX+ CXCR4+ modify disease progression in an amyotrophic lateral sclerosis model. Brain. 2007; 130(Pt 5):1289-305. DOI: 10.1093/brain/awm043. View

4.
Wang X, Michaelis E . Selective neuronal vulnerability to oxidative stress in the brain. Front Aging Neurosci. 2010; 2:12. PMC: 2874397. DOI: 10.3389/fnagi.2010.00012. View

5.
Cory A, Owen T, BARLTROP J, CORY J . Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture. Cancer Commun. 1991; 3(7):207-12. DOI: 10.3727/095535491820873191. View